Context: Single leg balance testing is a commonly used tool in sports medicine; however, there has been no consensus on trial duration needed to obtain reliable measures. Objective: This investigation sought to determine the minimum trial duration required to obtain the highest intrasession single and average trial reliability for single leg balance testing on stable and unstable surfaces using dominant and nondominant limbs. Design: Intrasession reliability. Setting: Biomechanics laboratory. Participants: 70 healthy (35 men, 35 women), physically active young adults aged 22.8 ± 2.8 y divided into 3 subgroups (n = 10, 30, 30) across a 3-phase study. Methods: 3 phases of single leg balance testing were performed. For phase 1, the duration of time each participant could maintain posture on each limb/surface were computed. Phase 2 considered performance for 6 cumulative time intervals (5s, 10s, 15s, 20s, 25s, 30s). Phase 3 served to solidify results of phase 2 by computing reliability of 15s trials. Main outcome measures: Overall stability index of the center of pressure and platform tilt. Results: Intraclass correlation coefficients for phase 2 ranged from .74 (5s interval for nondominant limb on unstable surface) to .94 (20s interval for nondominant limb on stable surface). Phase 3 intraclass correlation coefficients ranged from .66 to .78 for single trial and .85 to .92 for 3 trial average with coefficients of variation ranging from 23.9% to 40.4% for single trial and 13.8% to 23.0% for 3 trial average. Conclusions: These results ultimately suggest 15s as the optimal trial duration to provide reliable measures while reducing compensatory event occurrence.
Single leg balance testing is often used to detect balance deficits and musculoskeletal impairments. The increased challenge of single leg testing (SLT) may better reveal deficits, and particularly so for physically active individuals, that would otherwise be undetected through bilateral stance testing. When considering various orthopedic issues, further postural challenge can be accomplished by using unstable support surfaces. 1 Similar to bilateral stance testing, 2 trial duration is likely a potent factor influencing SLT reliability; however, few investigations have been conducted. Single leg trial durations have ranged from 5s to 30s. [3] [4] [5] A disadvantage of SLT is the frequent compensatory events occurrence 6 and their effect on support surface derived measures. Using the upper extremities or touching down with the nonstance limb are both used to correct transient losses of stability but will affect support surface measures differently. One approach to decrease compensatory events is to reduce trial duration; 5 however, short trial duration reliability remains largely unknown. The purpose of this investigation was to determine the minimum trial duration required for obtaining high relative and absolute intrasession reliability for SLT on stable and unstable surfaces using both dominant and nondominant limbs. We hypothesized that across both limbs on the stable and unstable surfaces, longer trials duration would demonstrate greater reliability but would plateau, and when taking into account compensatory events, an optimal trial duration could be identified.
Methods
Seventy healthy, physically active adults (Table 1) volunteered and provided written participation consent after receiving a study procedure overview. Participants completed medical history questionnaires to verify the absence of musculoskeletal, neurological or other health issues influencing single leg balance performance. Physically active was defined as participating in some form of physical exercise 3 days per week at least 30 minutes per session. 6 Three phases of data collection using separate participant samples for each phase to avoid confounding effects of repeated testing were designed. The 3 separate samples included an equal number of men and women. Phase 1 (n = 10) determined the maximum trial duration that could be successfully performed without a compensatory event by the majority of participants using their dominant (defined as their preferred limb used for kicking) and nondominant limbs on the stable (up to 120s) and unstable (up to 45s) surfaces. Phase 2 (n = 30) considered reliability changes across 5s cumulative intervals up to the maximum determined in phase 1. Based on the data from phase 2, the reliability of a proposed optimum trial duration was then examined in phase 3 (n = 30) on a single and average trial basis.
All testing was conducted using the Balance System SD (Biodex Medical Systems, Shirley NY), which quantifies balance with the platform in stable (fixed) or unstable (multiaxial) modes. During the stable mode, strain gauges provide data (40 Hz) for computation of 2 dimensional center of pressure location. During the unstable mode, the circular platform can passively tilt up to 20° from level in any direction, while potentiometers report (40 Hz) the degree of platform tilt about the medial-lateral and anterior-posterior axes. Platform stability has 12 levels of stability; for this study, platform stability was set to level 6. The display screen was covered during testing to eliminate visual feedback regarding the center of pressure or platform orientation.
For all data collection phases, participants performed 1 practice trial before 3 test trials of each limb/surface condition with 30s of rest (bilateral stance) allotted between trials. Limb testing order (dominant, nondominant) and surface (stable, unstable) were randomized between participants. Following a standardized protocol, participants' feet were aligned with the malleolar axis over medial-lateral platform axis and the anterior-posterior platform axis bisecting the heel. 6 Participants were instructed to look straight ahead while maintaining hands on their iliac crests with the nonstance limb maintained in slight hip and knee flexion while hanging freely at one's side throughout the entire trial. Participants were cued to "stand as motionless as possible" during stable surface trials to "stand with the platform as level and motionless as possible" during unstable surface trials. During phases 2 and 3, if a participant broke posture and committed any of the errors defined by the Balance Error Scoring System (BESS), 7 the trial was terminated and the participant was given 1 retest trial.
Data Reduction and Analysis
The duration of time each participation could maintain limb/surface trial without a compensatory event was tabulated. For phase 2, the center of pressure (stable surface trials) and platform orientation (unstable surface trials) data from each trial was exported from the Biodex SD software. The OSI, 3, 4 representing changes in the center of pressure/platform tilt, was computed using custom written scripts during the first 5s, 10s, 15s, 20s, 25s, and 30s of each trial. Higher indices are indicative of poorer balance performance. The number of participants that could complete each trial duration was tallied. OSI computations were conducted on available data; if a participant committed a compensatory event at 20s, only their data to the 20s was used. Scatter plots and Kendall's tau between the 3 trial averages and standard deviations suggested heteroscedasticity, thus natural logarithm transformations were applied to the OSI. 8 Intraclass correlation coefficients (ICCs) (2,3) were computed across the 3 trials for each time interval.
Similar to phase 2, the data from the 15s trials in phase 3 was used to compute the OSI. Heteroscedasticity was again evident; therefore natural logarithm transformations were applied. ICCs (2,1 and 2,3) were computed across the 3 trials of each limb/surface condition. Systematic bias (changes) between consecutive trials were examined with paired t tests. Finally, to determine OSI absolute reliability coefficients of variation were computed. 9 All statistical analyses were conducted using SPSS 21.0 statistical software (SPSS, Inc, Chicago, IL).
Results
During phase 1, 75% of the participants were able to maintain stance on each limb/surface for 45s without a compensatory event. For phase 2, 83% and 77% of the subjects were able to complete 3 trials of each limb/ surface condition for 15s and 30s, respectively (Table  2) . ICCs (Table 2 ) ranged from 0.74 to 0.94 with the ICCs 95% confidence intervals overlapping across the time intervals. Thus, phase 3 was designed to confirm the reliability of 15s trials.
While all participants could complete 3 stable surface trials on both limbs during phase 3, 4 participants could not complete some of the unstable surface trials. One participant could not complete trials successfully on either limb, 2 participants could not complete trials on the dominant limb, and 1 participant could not complete the trials on the nondominant limb. ICCs ranged from 0.66 to 0.78 for single trial and .85 to .92 for 3 trial average across the 3 15s trials of each limb/surface condition (Table 3) . Except for a significant performance decrease (higher OSI) between dominant limb-unstable surface trials 1 and 2, there were no significant systematic changes in 
Discussion
While the ICCs did not differ substantially between each trial duration interval, the results suggested a trial duration between 15s and 20s optimally balanced sufficient time for stable measures while minimizing compensatory events. In light of practitioners using SLT with individuals possessing challenged balance abilities, 15s trial durations were selected for further investigation. The phase 3 participants confirmed the absolute and relative reliability estimates for 15s trials. ICCs indicate whether individuals maintain their performance rank across repeated measurements. The 3 trial average coefficients from phase 3 exceeded the general guideline of that ICCs be greater than 0.75; 10 however, 2 of the single trial estimates failed to reach this guideline. ICCs are influenced by the range of scores from which they are computed. The dominant limb ICCs were slightly higher compared with the nondominant limb on the stable surface, whereas the nondominant limb ICCs were slightly higher for the unstable surface. These slight differences may be a function of score Abbreviations: OSI, Overall stability index; SD, standard deviation; DOM, Dominant limb; NDOM, Nondominant limb; ICC, Intraclass Correlation Coefficient; CI, Confidence Interval; FREQ, Number (n = 30) of subjects (percentage) that could not complete 3 successful trials (no compensatory events) at each time interval.
a Intraclass correlation coefficients after natural logarithm transformation.
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variability; the standard deviations were slightly higher for the dominant limb-stable surface and nondominant limb-unstable surface. Although our ICCs were slightly higher than previous reports using the Biodex Balance System 3,11 full comparison is confounded by slight stance position and trial duration differences, as well as the exact Biodex System used. 12 Consistent with many ratio-scaled measures, 8 our data demonstrated heteroscedasticity, suggesting that measurement error was related to score magnitude. Reporting the coefficient of variation allows measurement error to be scaled to score magnitude. The coefficients of variation for the single trials were almost double the magnitude of the 3 trial averages, confirming more precise performance estimation through the use of a 3 trial average. Adding and subtracting the product of an individual's score and the coefficient of variation creates an interval representing values within the margin of measurement error. In this manner, practitioners can determine whether changes in stability indices following intervention (ie, rehabilitation of an ankle sprain) are "real" versus measurement noise. Clinical meaningfulness of the coefficient of variations established in this study and performance changes exceeding measurement error is circumstance specific and cannot be provided by this investigation.
The purpose of considering the difference between trials was to determine if there was systematic bias (increases or decreases) between successive trials. Because the unstable surface is a relatively novel task, we expected to find slight improvements (smaller stability indexes) with successive trials. In comparison with the other surface/limb where near equal numbers of participants demonstrated OSI increases/decreases, slightly more participants demonstrated an OSI increase between trials 1 and 2 for the unstable dominant limb. This caused the significant systematic bias; however, the absolute magnitude of the deviations between trials was similar to many of the other limb/surface conditions. Thus, with the exception of the dominant limb on unstable surface, it appears that using 1 practice trial was sufficient to negate any underlying learning effects. Practitioners should include a practice trial in testing protocols.
In phase 3 single trial and average trial reliability were considered. While average trial reliability estimates are associated with higher reliability, completing multiple trials increases assessment time. Time with patients is limited and often involves other assessments besides balance; therefore, we also determined single trial reliability. The SLT results challenge the usefulness of using 1 trial to reflect SLT performance. Future research should consider a 2 trial average as a possible reliability-assessment time compromise as well as the intersession reliability of 15s trials. In addition, as this study only considered healthy physically active individuals, future research should also consider replicating phase 3 of the current study with various clinical populations. In conclusion, the current results ultimately suggest 15s as the optimal trial duration to provide reliable measures while reducing compensatory event occurrence. 
